Skip to main content

Table 3 Outcome of valve surgery within 30 days

From: A review of outcome following valve surgery for rheumatic heart disease in Australia

  All RHD-related Non-RHD P value
N = 17227 N = 1384 N = 15843
Initial admission
 Ventilation (hours) (median (IQR)) 11.0(6.8 – 19.0) 12.0(7.0 – 19.0) 11.0(6.7 – 19.0) 0.009
 Intensive care unit (ICU) stay (hours) (median (IQR)) 43.3(23.0 – 72.3) 42.0(23.0 – 70.8) 43.5(23.0 – 72.5) 0.350
 Post procedure length of stay (days) (median (IQR)) 8.0(7.0 – 13.0) 8.0(7.0 – 13.0) 8.0(7.0 – 13.0) 0.648
 Re-operation for valve dysfunction (%, 95 % CI) 0.2(0.1 – 0.3) 0.4(0.1 – 0.8) 0.2(0.1 – 0.3) 0.152
 Re-operation not related to valve dysfunction (%, 95 % CI) 7.0(6.6 – 7.4) 7.3(6.0 – 8.8) 7.0(6.6 – 7.4) 0.652
Mortality
 All cause (%, 95 % CI) 4.2(3.8 – 4.5) 3.1(2.2 – 4.3) 4.3(3.9 – 4.6) 0.058
 Cardiac cause (%, 95 % CI) 1.5(1.3 – 1.8) 1.5(0.9 – 2.4) 1.5(1.3 – 1.8) 0.122
 Non-cardiac cause (%, 95 % CI) 2.7(2.4 – 2.9) 1.6(1.0 – 2.6) 2.8(2.5 – 3.0) 0.907
 Readmission (%, 95 % CI) 11.2(10.7 – 11.7) 13.8(12.0 – 15.7) 11.0(10.5 – 11.5) 0.002
Other complications
 Readmission for valve dysfunction (%, 95 % CI) 0.2(0.1 – 0.4) 0 0.2(0.1 – 0.4) 0.205
 Acute kidney injury (%, 95 % CI) 6.3(5.9 – 6.7) 6.3(5.1 – 7.7) 6.3(5.9 – 6.7) 0.971
 New AF (% without prior AF, 95 % CI) 34.2(33.4 – 35.1) 33.3(30.1 – 36.6) 34.3(33.5 – 35.1) 0.564
 Stroke/ TIA (%, 95 % CI) 2.4(2.2 – 2.6) 1.6(1.0 – 2.4) 2.5(2.2 – 2.7) 0.044
 Deep sternal wound infection (%, 95 % CI) 0.9(0.8 – 1.1) 1.2(0.7 – 1.0) 0.9(0.8 – 1.1) 0.247
 Anticoagulant complication (bleeding or embolization) (%, 95 % CI) 1.7(1.5 – 1.9) 2.8(2.0 – 3.7) 1.6(1.4 – 1.8) 0.002
 Heart failure (%, 95 % CI) 1.9(1.5 – 2.2) 2.4(1.4 – 3.9) 1.8(1.5 – 2.1) 0.274
 Septicaemia (positive blood culture with signs of infection)(%, 95 % CI) 1.6(1.4 – 1.8) 0.4(0.8 – 2.1) 0.6(1.4 – 1.8) 0.476